A Study Of CinnoRA (Adalimumab-CinnaGen) And Adalimumab (Humira) In Healthy Subjects

Clinical trial NCT03273192 · COMPLETED

Trial details

NCT number: NCT03273192
Sponsor: Cinnagen
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Bioequivalence Phase 1

Start date: 2016-10-22
Primary completion: 2017-08-06
Enrollment: 74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.